|
Market Closed -
Xetra
11:35:29 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 4.780 EUR | +1.70% |
|
+11.16% | +29.19% |
| Market Cap | 227M 263M 213M 194M 365M 25.14B 371M 2.5B 977M 12.59B 987M 966M 41.83B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 227M 263M 213M 194M 365M 25.14B 371M 2.5B 977M 12.59B 987M 966M 41.83B | EV / Sales 2026 * |
0.29x | EV / Sales 2027 * | 0.28x |
| Free-Float |
12.27% | Yield 2026 * |
0.84% | Yield 2027 * | 0.84% |
| 1 day | +1.70% | ||
| 1 week | +11.16% | ||
| Current month | +16.02% | ||
| 1 month | +16.59% | ||
| 3 months | +32.04% | ||
| 6 months | +33.52% | ||
| Current year | +29.19% |
| 1 week | 4.36 |  | 4.78 |
| 1 month | 4.04 | | 4.78 |
| Current year | 3.22 | | 4.78 |
| 1 year | 2.88 | | 4.78 |
| 3 years | 2.28 | | 4.78 |
| 5 years | 2.28 | | 4.78 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 50 | - |
Nicola Bertrand
CTO | Chief Tech/Sci/R&D Officer | - | 2024-06-30 |
Martin Buse
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 2002-12-31 |
Michael Bock
BRD | Director/Board Member | 63 | 2005-05-24 |
| Director/Board Member | 63 | 2012-09-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | +11.16% | +55.19% | +62.59% | 263M | |
| -0.85% | -1.20% | +18.84% | +36.89% | 17.73B | |
| +3.73% | -0.27% | +14.05% | +85.04% | 13.41B | |
| +0.03% | -1.31% | +3.29% | +72.11% | 12.19B | |
| -0.57% | -1.25% | -32.53% | -52.87% | 11.97B | |
| -0.13% | -0.72% | +9.43% | +84.79% | 10.5B | |
| +1.68% | +4.28% | - | - | 9.72B | |
| -0.51% | -2.99% | -10.14% | -32.17% | 9.36B | |
| -0.13% | -0.16% | +14.25% | -20.57% | 7.31B | |
| +2.52% | -2.74% | -0.32% | +196.00% | 7.33B | |
| Average | +0.75% | +0.51% | +8.01% | +47.98% | 9.98B | |
| Weighted average by Cap. | +0.57% | -0.87% | +3.26% | +43.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 912M 740M 673M 1.27B 87.18B 1.29B 8.67B 3.39B 43.66B 3.42B 3.35B 145B | 803M 930M 755M 686M 1.29B 88.93B 1.31B 8.84B 3.46B 44.53B 3.49B 3.42B 148B |
| Net income | 36.66M 42.45M 34.45M 31.33M 58.91M 4.06B 59.88M 404M 158M 2.03B 159M 156M 6.75B | 38.2M 44.22M 35.89M 32.64M 61.37M 4.23B 62.38M 421M 164M 2.12B 166M 162M 7.04B |
| Net Debt | - | - |
Employees
7,048
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | €4.780 | +1.70% | 0 |
| 26-08-13 | €4.700 | 0.00% | 30,020 |
| 26-08-12 | €4.700 | +2.62% | 3,664 |
| 26-08-11 | €4.580 | +0.44% | 439 |
| 26-08-10 | €4.560 | +6.05% | 42,209 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.780EUR
Average target price
7.300EUR
Spread / Average Target
+52.72%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
